{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:03:57Z","timestamp":1790247837359,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673362"],"award-info":[{"award-number":["81673362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690261"],"award-info":[{"award-number":["81690261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.actbio.2017.10.019","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T01:01:31Z","timestamp":1507856491000},"page":"237-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses"],"prefix":"10.1016","volume":"64","author":[{"given":"Man","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2017.10.019_b0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2010.10.020","article-title":"mRNA as gene therapeutic: how to control protein expression","volume":"150","author":"Tavernier","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.019_b0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejpb.2008.09.016","article-title":"Current prospects for mRNA gene delivery","volume":"71","author":"Yamamoto","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2017.10.019_b0015","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/jvi.56.2.628-632.1985","article-title":"In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14","volume":"56","author":"Mizutani","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2017.10.019_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2017.10.019_b0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41598-017-00193-w","article-title":"An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model","volume":"7","author":"Chahal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2017.10.019_b0030","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Karik\u00f3","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2017.10.019_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.actbio.2017.10.019_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2013.01.033","article-title":"Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells","volume":"167","author":"Andries","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.019_b0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2010.09.007","article-title":"Delivery of messenger RNA using poly(ethylene imine)\u2013poly(ethylene glycol)-copolymer blends for polyplex formation: Biophysical characterization and in vitro transfection properties","volume":"148","author":"Debus","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.019_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni085","article-title":"A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids","volume":"33","author":"Read","year":"2005","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.actbio.2017.10.019_b0055","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2017.10.019_b0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2015.986104","article-title":"Lipid-based mRNA vaccine delivery systems","volume":"14","author":"Midoux","year":"2015","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.actbio.2017.10.019_b0065","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.biomaterials.2009.02.050","article-title":"High performance mRNA transfection through carbonate apatite\u2013cationic liposome conjugates","volume":"30","author":"Zohra","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00262-005-0064-z","article-title":"Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor\/self antigen","volume":"55","author":"Hess","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.actbio.2017.10.019_b0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2012.202","article-title":"Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines","volume":"21","author":"Pollard","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2017.10.019_b0080","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1093\/nar\/29.18.3882","article-title":"Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells","volume":"29","author":"Bettinger","year":"2001","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.actbio.2017.10.019_b0085","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/adma.201200446","article-title":"Engineering nano- and microparticles to tune immunity","volume":"24","author":"Moon","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2017.10.019_b0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1670","article-title":"Dendritic-cell trafficking to lymph nodes through lymphatic vessels","volume":"5","author":"Randolph","year":"2005","journal-title":"Nat. Rev.Immunol"},{"key":"10.1016\/j.actbio.2017.10.019_b0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biomaterials.2016.05.008","article-title":"Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy","volume":"98","author":"Qian","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","article-title":"Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity","volume":"130","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2017.10.019_b0110","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2017.10.019_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.actbio.2017.10.019_b0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11095-014-1441-0","article-title":"Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration","volume":"32","author":"Liu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2017.10.019_b0125","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2017.10.019_b0130","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1002\/anie.201002221","article-title":"Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system","volume":"49","author":"Skwarczynski","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2017.10.019_b0135","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1002\/anie.201300390","article-title":"Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid","volume":"52","author":"Cai","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2017.10.019_b0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2017.10.019_b0145","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2017.10.019_b0150","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.actbio.2013.12.036","article-title":"Engineering vaccines and niches for immune modulation","volume":"10","author":"Purwada","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2017.10.019_b0155","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1016\/j.actbio.2013.06.010","article-title":"Size effect of amphiphilic poly(\u03b3-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo","volume":"9","author":"Shima","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2017.10.019_b0160","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actbio.2017.10.019_b0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nbt.2344","article-title":"Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens","volume":"30","author":"Wegmann","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2017.10.019_b0170","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/mt.2010.222","article-title":"Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses","volume":"19","author":"Torrieri-Dramard","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2017.10.019_b0175","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1016\/j.biomaterials.2011.03.004","article-title":"Maltosylated polyethylenimine-based triple nanocomplexes of human papillomavirus 16L1 protein and DNA as a vaccine co-delivery system","volume":"32","author":"Cho","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0180","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.biomaterials.2014.01.065","article-title":"A mannosylated cell-penetrating peptide-graft-polyethylenimine as a gene delivery vector","volume":"35","author":"Hu","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","article-title":"Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2017.10.019_b0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.actbio.2017.01.005","article-title":"The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response","volume":"50","author":"Wafa","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2017.10.019_b0195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jgm.874","article-title":"Low molecular weight polyethylenimines linked by \u03b2-cyclodextrin for gene transfer into the nervous system","volume":"8","author":"Tang","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.actbio.2017.10.019_b0200","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1021\/nn502975r","article-title":"Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity","volume":"8","author":"Muraoka","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2017.10.019_b0205","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.4049\/jimmunol.162.4.2044","article-title":"Human effector memory T cells express CD86: a functional role in naive T cell priming","volume":"162","author":"Jeannin","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2017.10.019_b0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.actbio.2017.10.019_b0215","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2174\/0929867311320200008","article-title":"Functional characterization of a PEI-CyD-FA-coated adenovirus as delivery vector for gene therapy","volume":"20","author":"Hong","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actbio.2017.10.019_b0220","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2147\/IJN.S42440","article-title":"Low-weight polyethylenimine cross-linked 2-hydroxypopyl-\u03b2-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA","volume":"8","author":"Li","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2017.10.019_b0225","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s11095-014-1372-9","article-title":"Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants","volume":"31","author":"Jiang","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2017.10.019_b0230","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/IJN.S43074","article-title":"Polyethylenimine(600)-\u03b2-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cells","volume":"8","author":"Tong","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2017.10.019_b0235","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.biomaterials.2009.06.051","article-title":"The gene transfection efficiency of a folate\u2013PEI600\u2013cyclodextrin nanopolymer","volume":"30","author":"Yao","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0240","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.biomaterials.2009.11.012","article-title":"Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-\u03b3-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2017.10.019_b0245","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/S0264-410X(01)00188-8","article-title":"Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery","volume":"19","author":"Oh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2017.10.019_b0250","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1365-2567.2000.00069.x","article-title":"Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli","volume":"100","author":"Shaw","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.actbio.2017.10.019_b0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature08604","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2017.10.019_b0260","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.20041236","article-title":"Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes","volume":"200","author":"Miller","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actbio.2017.10.019_b0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni928","article-title":"Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes","volume":"4","author":"Bousso","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2017.10.019_b0270","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-065X.2007.00551.x","article-title":"Dendritic cell subsets in health and disease","volume":"219","author":"Ueno","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actbio.2017.10.019_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00157","article-title":"Skin-resident antigen-presenting cells: Instruction manual for vaccine development","volume":"4","author":"Fehres","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2017.10.019_b0280","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/erv.12.81","article-title":"Optimizing efficacy of mucosal vaccines","volume":"11","author":"Gebril","year":"2012","journal-title":"Exp. Rev. Vaccines"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706117306359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706117306359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:04:54Z","timestamp":1761671094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706117306359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":56,"alternative-id":["S1742706117306359"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2017.10.019","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2017.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}